Pioneering synthetic biology company, SGI-DNA, releases a new protein expression system, accelerating into vaccinees and personalized medicines by delivering up to 4x more soluble protein than traditional E. coli methods in half the time San Diego, California – SGI-DNA, creators of the BioXp 3200 System and Gibson Assembly Reagents, has launched Vmax X2 Competent Cells, […]

Following extensive support of, and collaboration with, public health professionals in China, Oxford Nanopore has shipped an additional 200 MinION sequencers and related consumables to China. These will be used to support the ongoing surveillance of the current coronavirus outbreak, adding to a large number of the devices already installed in the country. Oxford Nanopore […]

BGI Group responds to coronavirus crisis by providing reagent kits for molecular 2019-nCoV testing by next-generation sequencing and RT-PCR Ares Genetics to launch next-generation sequencing testing service for infection control and monitoring of 2019-nCoV evolution using BGI Group reagents Ares Genetics, Curetis Group and BGI Group to collaborate in the distribution of next-generation sequencing and […]

Complete qPCR panel of the CDC-published sequences for coronavirus detection in addition to preferred pricing on gBlocks fragments and synthetic genes ordered for vaccine development Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced that it is accepting pre-orders from the global public health and research communities for qPCR primers and probes designed to detect […]

Robust panel enables accurate and comprehensive constitutional genetic aberration screening in one assay   Oxford, UK – Oxford Gene Technology (OGT), A Sysmex Group Company, has launched a transformative next-generation sequencing (NGS) panel for constitutional cytogenetics research. The CytoSure™ Constitutional NGS Panel contains the most up-to-date, hand-curated content for intellectual disability (ID) and developmental delay (DD) research. Delivering accurate […]

BGI Group responds to coronavirus crisis by providing reagent kits for molecular 2019-nCoV testing by next-generation sequencing and RT-PCR Ares Genetics to launch next-generation sequencing testing service for infection control and monitoring of 2019-nCoV evolution using BGI Group reagents Ares Genetics, Curetis Group and BGI Group to collaborate in the distribution of next-generations sequencing and […]

NGS Accelerating Viral Identification and Control Measures   On December 31, 2019, the World Health Organization was alerted to several cases of pneumonia in Wuhan City, Hubei Province of China that appeared to be caused by a novel virus with unknown etiology. One week later, Chinese authorities confirmed that they had identified a new virus from the […]

STATE COLLEGE, Pa. — INDIGO Biosciences, Inc. (INDIGO), the recognized industry leader in nuclear receptor and in vitro toxicology testing solutions, has announced a record earnings year for 2019. With final numbers to be released to Company Shareholders in the upcoming weeks, INDIGO showed more than a twenty percent increase in revenue and a thirty percent […]

Complete qPCR panel of the CDC-published sequences for coronavirus detection in addition to preferred pricing on gBlocks fragments and synthetic genes ordered for vaccine development CORALVILLE, IA  – Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced that it is accepting pre-orders from the global public health and research communities for qPCR primers and probes designed […]

TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has received notification of validation of European patent number EP 3356554 for its methods for subtyping diffuse large B-cell lymphoma (DLBCL), effective October 2019. HTG was previously granted a patent for this […]